We show you our most important and recent visitors news details Abu Dhabi makes groundbreaking progress in stem cell treatment of COVID-19 in the following article
Hind Al Soulia - Riyadh - The Abu Dhabi Stem Cell Centre has now treated more than 2000 patients suffering from the pandemic, with 1200 already fully recovered from the effects of the virus.
Saturday 27/06/2020
Progress made in COVID-19 stem cell treatment by ADSCC. (WAM)
ABU DHABI -The Abu Dhabi Stem Cell Centre (ADSCC) announced this week that it had succeeded in ramping up the number of coronavirus treatments from 73 in initial clinical trial.
This breakthrough comes following a decision by the Emirati government to make treatment available free of charge for all moderate-to-high risk COVID-19 patients in the country.
A treatment, branded UAECell19, has previously demonstrated efficacy with no significant changes in adverse events reported, an absence of any unexpected serious reactions (such as anaphylaxis, allergies or sudden death) and no reports of any lung complications as determined by radiological exams from inhalation of the nebulised product.
ADSCC has now treated more than 2000 patients suffering from COVID-19, with 1200 already fully recovered from the effects of the virus.
A team of doctors and researchers at ADSCC, led by doctor Yendry Ventura, announced in May they had developed a new treatment for COVID-19 patients.
UAECell19, an autologous stem cells based therapy, appears to help the body fight the virus and make the disease less harmful.
Following an initial trial, researchers were able to conclude that UAECell19 reduced the duration of hospitalisation from 22 days to just six, when compared to patients who had received standard treatment.
Further analyses revealed that patients treated with the stem cells were 3,1 times more likely to recover in less than seven days than those treated with standard therapy.
67 percent of the patients who received the stem cells treatment owed their recovery to the new treatment.
ADSCC has since secured intellectual property rights protection for UAECell19, which opens the way for the treatment to be shared widely so more patients can benefit.
ADSCC said researchers are at various stages of several investigatory efforts to establish effectiveness (Phase 3 trial), optimal efficacy of dosage, and efficacy to treat other respiratory diseases such asthma, COPD, and cystic fibrosis.
These were the details of the news Abu Dhabi makes groundbreaking progress in stem cell treatment of COVID-19 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at The Arab Weekly and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
